Related Experiment Videos
Islet transplantation and glucose regulation
1Nuffield Department of Surgery, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. derek.gray@surgery.oxford.ac.uk
World Journal of Surgery
|May 10, 2001
Summary
Islet transplantation shows promise for diabetes treatment but faces challenges with limited islet yield and long-term graft function. Rodent models demonstrate successful glucose metabolism with sufficient islet mass.
Area of Science:
- Endocrinology
- Transplantation Biology
- Metabolic Diseases
Background:
- Islet transplantation is an emerging therapy for diabetes, showing limited success in humans.
- Challenges include poor islet yield and suboptimal graft function, particularly in allotransplantation and autotransplantation.
- Current intraportal transplantation sites show limited long-term graft survival, often deteriorating within 5 years.
Purpose of the Study:
- To review the current state of islet transplantation for diabetes treatment.
- To identify limitations in islet yield and graft function in human and animal models.
- To explore potential improvements and alternative transplantation sites.
Main Methods:
- Review of experimental research and clinical applications of islet transplantation.
- Analysis of factors affecting islet yield and graft survival.
- Comparison of outcomes across different species and transplantation sites.
Main Results:
- Human islet transplantation is limited by insufficient islet mass and poor long-term graft function.
- Alternative sites like spleen or kidney capsule show potential but are limited by islet mass.
- Rodent models with sufficient islet mass achieve near-normal glucose metabolism and long-term function.
Conclusions:
- Improving islet yield and long-term graft survival are critical for successful human islet transplantation.
- Further research into optimal transplantation sites and methods is needed.
- Rodent models provide valuable insights into achieving functional islet mass equivalence.